More than a year after it received a warning letter from the U.S. Food and Drug Administration, Anulex Technologies, a soft tissue repair company in Minnesota, announced that it has resolved the matter.
A review of life science current events reported by MedCity News this week: Layoffs occur at Anulex following FDA’s warning letter. Following a February warning letter from the U.S. Food and Drug Administration, Anulex Technologies has had to adjust by having a round of layoffs. President and General Manager Tim Miller declined to say how […]
Monica Vajani, Executive Director for mHUB’s MedTech Accelerator, discusses how mHUB is helping innovators transition healthcare towards value-based care.
Following a February warning letter from the U.S. Food and Drug Administration, Anulex Technologies has had to adjust by having a round of layoffs. President and General Manager Tim Miller declined to say how many people were let go but acknowledged that such letters were “extremely disruptive to business. ” The Minnetonka, Minnesota-based medical device […]
Venture capitalists may be stingy these days but it seems what little money they’re willing to spend is going toward Anulex Technologies Inc. in Minnetonka, Minn. The company said Thursday that it raised $18 million in a Series E financing round. And Anulex still plans to raise at least $2 million more, said CFO David […]
Fresh off the launch of a next-generation version of its spinal-tissue repair device, Anulex Technologies has raised $3.8 million, according to a Securities and Exchange Commission filing. The funding comes in the form of debt and options, and was raised from 11 investors. Last month, Anulex began marketing a new version of its Xclose tissue-repair […]
The Minnesota Medical Device Alliance Steering Committee, made up of some of the state's most prominent investors, attorneys and executives, is hosting a meeting in February to discuss ways to push back against critics of the 510(k) program.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The company is focused on selling the Xclose, a device that uses small braided polyester bands to make an X-shaped stitch over openings in the soft tissue around the spine.